LONDON - Proctor and Gamble (P&G) is applying its expertise as a consumer products giant to get a patient's eye view of disease and use the insights to inform development programs with biotech partners. (BioWorld International)

A month after sealing a joint venture deal focused on microRNA, Isis Pharmaceuticals Inc. continues to capitalize on its growing antisense platform by licensing rights to an inhaled asthma product to newly formed Altair Therapeutics Inc. (BioWorld Today)